Ethnobotanical Description and Biological Activities of

Senna alata by Oladeji, O.S et al.
Review Article
Ethnobotanical Description and Biological Activities of
Senna alata
Oluwole Solomon Oladeji ,1,2 Funmilayo Enitan Adelowo,2 Abimbola Peter Oluyori,1
and Deborah Temitope Bankole 1
1Natural Products Research Unit, Industrial Chemistry Programme, Department of Physical Sciences,
Faculty of Pure and Applied Sciences, Landmark University, Omu-Aran, Nigeria
2Department of Pure and Applied Chemistry, Faculty of Pure and Applied Sciences, Ladoke Akintola University of Technology,
PMB 4000, Ogbomoso, Nigeria
Correspondence should be addressed to Oluwole Solomon Oladeji; oladeji.oluwole@lmu.edu.ng
Received 24 September 2019; Revised 16 January 2020; Accepted 27 January 2020; Published 21 February 2020
Academic Editor: Marisa Colone
Copyright © 2020 Oluwole Solomon Oladeji et al. *is is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the original work is
properly cited.
Senna alata is a medicinal herb of Leguminosae family. It is distributed in the tropical and humid regions.*e plant is traditionally
used in the treatment of typhoid, diabetes, malaria, asthma, ringworms, tinea infections, scabies, blotch, herpes, and eczema. *e
review is aimed at unveiling the ethnobotanical description and pharmacological activities of S. alata. Different parts of the plant
are reported in folkmedicine as therapeutic substances for remediation of diverse diseases and infections.*e extracts and isolated
compounds displayed pronounced pharmacological activities. Display of antibacterial, antioxidant, antifungal, dermatophytic,
anticancer, hepatoprotective, antilipogenic, anticonvulsant, antidiabetic, antihyperlipidemic, antimalarial, anthelmintic, and
antiviral activities could be due to the array of secondary metabolites such as tannins, alkaloids, flavonoids, terpenes, an-
thraquinone, saponins, phenolics, cannabinoid alkaloids, 1,8-cineole, caryophyllene, limonene, α-selinene, β-caryophyllene,
germacrene D, cinnamic acid, pyrazol-5-ol, methaqualone, isoquinoline, quinones, reducing sugars, steroids, and volatile oils
present in different parts of the plant. *e review divulges the ethnobotanical and pharmacological activities of the plant and also
justifies the ethnomedical claims. *e significant medicinal value of this plant necessitates a scientific adventure into the bioactive
metabolites which constitute various extracts.
1. Introduction
*e primary and safest therapeutic approach since prehis-
toric time is herbal medicine which has displayed significant
role in primary health care development [1]. *e World
Health organization (WHO) appraised that 80% of inhab-
itants in developing countries basically rely on herbal
medicines [2, 3]. Recently, it was discovered that one-third
of the commonly used drugs are obtained from natural
sources. *is has led to the documentation of about
40,000–70,000 medicinal plant species with outstanding
therapeutic potentials [4].
*e scientific appraisal of the pharmacological activities
of herbal plants revealed about 200,000 phytochemicals.
*ese compounds contribute to the apparent medicinal
activities displayed by plants and invariably justify the
involvement of natural products in the development of
novel drugs [5]. Despite these achievements, the use of
herbal drugs was not universally accepted in contemporary
medicine due to lack of scientific evidence and proper
documentation. However, the significance of herbs in
pharmacology has necessitated the provision of scientific
facts on bioactive compounds and pharmacological assays
of plants [6, 7].
Medicinal plants with immense biological applications
have been viewed as the principal sources of therapeutic
substances which could lead to novel therapeutic com-
pounds. *e search for these compounds from medicinal
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plants usually ends in the isolation of novel compounds and,
eventually, drug developments [8]. Several medicinal plants
with diverse interesting pharmacophore have been scien-
tifically investigated, and one of these plants is Senna alata.
S. alata, also known as Cassia alata, is a widely dis-
tributed herb of the Leguminosae family. It is commonly
known as candle bush, craw-craw plant, acapulo, ringworm
bush, or ringworm plant. *e plant is commonly found in
Asia and Africa, and has many local names [9]. It has arrays
of bioactive chemical compounds. Some of the reported
chemical constituents are phenolics (rhein, chrysaphanol,
kaempferol, aloeemodin, and glycosides), anthraquinones
(alatinone and alatonal), fatty acids (oleic, palmitic, and
linoleic acids), steroids, and terpenoids (sitosterol, stig-
masterol, and campesterol) [10, 11]. *ese secondary me-
tabolites are reported to display numerous biological
activities [12–17].
*e flower, root, leaves, seed, and bark displayed diverse
biological activities [18–20]. *ese pharmacological activi-
ties include antimicrobial [21–23], antifungal [24], anti-
cryptococcus [25], antibacterial [26, 27], antitumor [28],
anti-inflammatory [29, 30], antidiabetic [31], antioxidant
[18], wound healing [32], and antihelmintic activities [33].
In recent times, the outbreak of drug-resistant diseases has
led to several health issues. In an attempt to resolve these
issues, pharmacological research has been tailored towards
the discovery of innovative, potent, and safe drugs from
natural compounds. *is review appraises the ethnobo-
tanical and pharmacological activities of S. alata, thus jus-
tifying diverse traditional applications of the plant.
2. Review Methodology
Relevant documents were obtained from major scientific
catalogues such as Pubmed, Google Scholar, EBSCO, Sci-
Finder, Scopus, Medline, and Science Direct. Many publi-
cations sites were queried to procure information on
ethnobotanical description and pharmacological activities of
S. alata.
3. Ethnobotanical Description
3.1. Description and Classification. S. alata (L.) Roxb. is a
flowering shrub of the Fabaceae family. It has the name
“candle bush” owing to the framework of its inflorescences
[34]. It is an annual and occasionally biannual herb, with an
average height of 1 to 4m, burgeoning in sunlit and humid
zones. *e leaves are oblong, with 5 to 14 leaflet sets, robust
petioles (2 to 3mm), caduceus bracts (2× 3 by 1× 2 cm), and
dense flowers (20× 50 by 3× 4 cm). Zygomorphic flowers
have bright yellow color with 7 stamens and a pubertal
ovary. *e fruit exists as a 10 to 16×1.5 cm tetragonal pod,
thick, flattened wings, brown when ripe with many dia-
mond-shaped brown seeds. It is propagated by seeds and
dispersed to about 1,500m above the sea level [35, 36].
Taxonomically, S. alata is classified as kingdom: Plantae;
order: Fabales; family: Fabaceae; subfamily: Caesalpinioi-
deae; tribe: Cassieae; subtribe: Cassiinae; genus: Senna;
species: S. alata.
3.2. Geographical Distribution. S. alata is widely distributed
in Ghana, Brazil, Australia, Egypt, India, Somalia, Sri Lanka,
and all over Africa [37]. It is an ornamental plant native to
the Amazon Rainforest [38]. Like other Senna species, it is
cultivated in humid and tropic regions of Africa, Asia, West
Indices, Mexico, Australia, South America, the Caribbean
Islands, Polynesia, Hawaii, Melanesia, and different parts of
India [39]. In Philippines, *ailand, and Indonesia, this
shrub is widely dispersed and is cultivated for medicinal
purposes [40].
3.3. Ethnobotanical Uses. In Ayurvedic, Sinhala, Chinese,
and African traditional medicine, various parts of S. alata
have shown diverse therapeutic activities in diseases control.
In northern Nigeria, the stem, leaf, and root decoctions is
used in treatment of wound, skin and respiratory tract in-
fection, burns, diarrhoea, and constipation [41, 42]. Also, in
the south-western regions, leaf decoction serves as an an-
tidote to body and abdominal pain, stress, and toothache
[43]. It also cures dermal infections, convulsion, and as
purgative [44, 45]. In Egypt, the leaf decoction was observed
to be used as a bowel stimulant to stimulate peristaltic
shrinkages and decrease water absorption from the colon in
attempt to prevent constipation [46]. In Cameroon, the
stem, bark, and leaves were reported to be used as a remedy
for gastroenteritis, hepatitis, ringworm, and dermal infec-
tions [47].
In India, Philippines, and China, S. alata’s stem, bark,
and leaf decoction were found to be effective in treating
haemorrhoids, inguinal hernia, syphilis, intestinal parasit-
osis, and diabetes [48]. Currently, seeds and roots are used in
regulating uterus disorder and worms [18, 49]. *e leaves
and flowers are typically used as antifungal agents and
laxatives [35]. In China, the seeds are used in treating asthma
and to improve visibility [50]. In Guatemela, Brazil, and
Guinea, the whole plant is currently used in the treatment of
flu and malaria [36]. *e flower and leaves decoction was
observed to be used in treatment of ringworms, scabies,
blotch, eczema, scabies, and tine infections [11, 51]. *e
leaves are currently used in Sierra Leone to relieve abortion
pain and facilitate baby delivery [51]. In west and east Africa,
bark decoction is spread on cuts during tribal mark incision
and tattoo making [52]. In China, India, Benin republic,
Ghana, Nigeria, and Togo, the whole plant is used as a
curative for Diabetes mellitus [34, 53]. Fresh leaves of the
plant are used in the treatment of skin rashes, mycosis, and
dermatitis [54]. From the traditional uses, the frequent use of
S. alata leaves is more than that of roots, flowers, roots, and
stem-bark owing to more active metabolites reported in the
leaves. Besides its pharmacological activities, it is processed
into capsule, pellet, and tea in Nigeria for preventing diseases
and maintaining sound health.
3.4. Pharmacological Activities. Medicinal plants belonging
to the Fabaceae family have extensively been investigated for
their pharmacological activities. Plants synthesised array of
secondary metabolites which contribute to its therapeutic
activities (Figure 1). *erapeutic appraisal of S. alata
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authenticates the ethnobiological claims and establishes the
pharmacological activities (Table 1). *ere are many pub-
lished articles connected to diverse therapeutic activities of S.
alata which are mainly related to antibacterial, antidiabetic,
antilipogenic, antifungal, antioxidant, dermatophytic, anti-
hyperlipidemic, and anthelmintic activities among others.
Few studies have also reported its antimalarial activities.
3.4.1. Antibacterial Activities. *e antibacterial potentials
of medicinal herbs are appraised using zone of inhibition
(ZOI) or minimum inhibitory concentration (MIC). *e
in vivo antibacterial potential of S. alata was assessed
against methicillin-resistant S. aureus (MRSA), extended
spectrum beta-lactamase, and carbapenemase-resistant.
Enterobacteriaceae was isolated from infectious patients,
via Mueller–Hinton broth via the microdilution tech-
nique. *e extract showed significant activities at 512mg/
ml due to the flavonoids, quinones, tannins, sterols, al-
kaloids, and saponins analysed [75]. S. alata leaves col-
lected from an Indian aboriginal tribe, displayed
significant ZOI of 21 to 27mm against clinical isolates of
multidrug-resistant (MDR) bacteria, obtained from in-
fected patients, when subjected to ASTs via Kirbye Bauer’s
disc diffusion assay (KBDD) [58].
Ciprofloxacin (30 μg/disc) and vacuum liquid chro-
matographic (VLC) fractions of S. alata methanolic extract
were assessed against Staphylococcus aureus, Bacillus subtilis,
Bacillus cereus (Gram positive), Shigella boydii, Shigella
dysenteriae, Pseudomonas aureus, Vibrio mimicus, Salmo-
nella paratyphi, Vibrio parahaemolyticus, and Salmonella






































































Figure 1: Bioactive compounds with therapeutic potencies in S. alata.
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fractions exhibited significant inhibitory activities against
bacteria isolates at 100 µg/ml [76].
Bioactive compounds such as kaempferol, luteolin, and
aloe emodin isolated from the methanolic leaves extract was
assessed against MDR bacteria strains. Aloe emodin
exhibited strongMIC activities (4 to 128 μg/ml).*emarked
activities could be linked to the anthraquinone and flavo-




D-allopyranoside isolated from chloroform, ethanol, petro-
leum ether, methanol, and aqueous leaves extract of S. alata,
significantly inhibited the growth of B. subtilis, V. cholerae,
Streptococcus sp., S. aureus, and E. coli.*e extracts displayed
pronounced activities which are in close proximity to peni-
cillin, chloramphenicol, fluconazole, and ciprofloxacin [77].
Anthraquinone and flavonoid glycosides detected in S.
alata extracts significantly inhibited the growth of E. coli and
S. aureus with ZOI between 9.7 and 14.8mm [22, 23]. *e
crude extracts and isolates obtained from purified fractions of
S. alata flower extract (anthraquinone glycosides, steroids,
tannins, and volatile oils) were assessed on selected bacteria
isolates. Strong inhibitory activities were displayed at MIC of
500mg/ml against the clinical isolates of S. faecalis, B. subtilis,
S. aureus, Pseudomonas putida, andM. Luteus.At 500mg/ml,
ZOI of 10 to 25mmwas observed, with close proximity to the
inhibitory activities displayed by streptomycin, penicillin,
and methicillin [41]. *e synergic effect of Eugenia uniflora
and S. alata leaves was examined on clinical isolates of B.
subtilis and S. aureus. *e dried leaves were processed into a
local antiseptic herbal soap and the antibacterial potential was
assessed via hole-in-plate agar diffusion assay.*e herbal soap
significantly inhibited the growth of the tested organisms [78].
3.4.2. Antioxidant Activities. *e antioxidant or scavenging
activities is important in appraisal of therapeutic potential of
medicinal herbs. Plants played significant role in protecting
cell against oxidative stress caused by active free radicals
[79]. *e free radical scavenging potentials of plants are
appraised by antibiotic sensitivity tests (ASTs); 2,2-diphenyl-
1-picrylhydrazyl (DPPH); ferric-reducing antioxidant power
(FRAP); 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic
acid) (ABTS); hydroxyl radical scavenging activity (HRSA),
and metal ion chelating activity (MICA). *e methanolic
and n-hexane leaves extracts of S. alata were explored for
their scavenging effects via DPPH assay. *e methanolic
extract displayed pronounced scavenging activities when
compared to n-hexane extract. *e methanolic extract was
fractionated, leading to isolation of three major bioactive
compounds (kaempferol, butylated hydroxytoluene, and
emodin). *e kaempferol fraction displayed pronounced
scavenging activity than the butylated hydroxytoluene and
emodin fractions [80]. Several bioactive compounds such as
ascorbic acid, flavonoids, tocopherol, anthraquinone, and
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Different parts of S. alata, significantly inhibited the
action of free radicals causing oxidative stress [82]. *e in
vitro DPPH assay of ethyl acetate-DCM, methanol-DCM,
and oil fractions of S. alata leaves was assessed using
L-ascorbic acid as control. *e radical scavenging activities
measured at 517 nm significantly inhibited the free radicals
at 500 g/ml. *e concentration at 50% inhibition (IC50) of
the fractions revealed activities of methanol-DCM (65.03%),
ethyl acetate-DCM (62.33%), and oil fraction (64.10%). *e
strong scavenging activities could be due to polyphenol and
flavonoid analysed [76].
3.4.3. Antifungal Activities. Several bioactive compounds
isolated from S. alata exhibit strong in vitro and in vivo
antifungal activities. *e antifungal activities of cannabinoid
alkaloid (4-butylamine 10-methyl-6-hydroxy cannabinoid
dronabinol), 1,8-cineole, caryophyllene, limonene, α-seli-
nene, β-caryophyllene, germacrene D, hexadecanoic acid
methyl ester, hexadecanoic acid, (6Z)-7,11-dimethyl-3-
methylidenedodeca-1,6,10-triene, octadecanoic acid methyl
ester, cinnamic acid, 3,7-dimethylocta-1,6-diene, pyrazol-5-
ol, flavonol and gallic acid, methaqualone, and isoquinoline
have been explored [51,83–85].
Volatile oils extracted from S. alata flowers were assessed
against standard strains and clinical isolates of Candida and
Aspergillus species. *e oils significantly inhibited the
growth of the tested microbes [86]. *e methanolic extract
and purified n-hexane and ethanolic fractions of S. alata
flower displayed strong inhibitory activities against A. Niger,
C. utilis, G. candidum, A. brevipes, and Penicillium species
with an MIC of 0.312 to 5mg/ml. However, at different
concentrations, the purified fractions exhibited prominent
inhibitory activities than the methanolic extracts. Likewise,
mycelia growth was significantly inhibited by the purified
fractions, with a total suppression of sporulation for 96 h at
2mg/ml, compared to less sporulation after 48 h for
methanolic extracts [87].
*e aqueous and ethanolic leaf and bark extracts of S.
alata was assessed via disc diffusion assay againstM. canis,
C. albicans, and A. fumigatus. *e bark extracts displayed
prominent concentration-dependent susceptibility against
C. albicans. On the contrary, the aqueous extract showed a
strong ZOI of 12 and 16mm, while ethanolic extracts
exhibited 10 and 14mm. However, tioconazole displayed
strong inhibitory activities of 18mm which are signifi-
cantly higher than the extracts at equivalent concentration
[64].
S. alata flowers and leaves collected from Ogbomoso,
Southwest Nigeria, were examined in an attempt to justify
the indigenous claims of its antifungal efficacy. In vitro
antifungal activities of ethanolic and methanolic extracts
were investigated using the disc diffusion approach. Etha-
nolic extracts showed pronounced inhibitory activities when
compared to methanolic extracts. *e IC50 value of the
ethanolic extract was two folds higher than the methanolic
extracts against the fungi isolates. *e inhibitory activities
displayed could be due to methaqualone, cinnamic acid,
isoquinoline, and toluidine detected [71].
3.4.4. Dermatophytic Activities. Currently, the leaves,
flowers, and bark of S. alata are used for treating various
kinds of skin infections and diseases. In *ailand, the plant
was mentioned as one of the 54 medicinal plants used for
treating scabies, shingles, urticarial, itching, pityriasis ver-
sicolor, and ringworm [88]. *e dermatophytic activities
displayed by S. alata are linked to the bioactive compounds
such as anthranols, anthrones, flavonoids, phenols, tannins,
and anthracene derivatives [89]. Leaves decoction displayed
strong inhibitory activities against S. pyogenes, S. aureus, K.
pneurnoniae, E. coli, S. rnarcescens, P. cepacia, and P. aer-
uginosa [90, 91].
Cannabinoid alkaloid (4-butylamine 10-methyl-6-hy-
droxy cannabinoid dronabinol) and apigenin isolated from S.
alata seeds were incorporated in a local antiseptic soap. *e
soap significantly hindered the spread of ringworms, eczemas,
carbuncles, boils, infantile impetigo, and breast abscess [84].
*e leaf, stem-bark, flower exudates, and ethanolic leaf extract
examined against clinical isolates ofT. jirrucosum,M. canis, T.
mentagrophyte, E. jlorrcosum, B. dermatitidis, A. flavus, andC.
albicans displayed strong inhibitory activities against the
causative organisms [18,92–94].
3.4.5. Antilipogenic, Antidiabetic, and Antihyperlipidemic
Activities. In Africa and Asia, S. alata leaves and flowers are
currently used to regulate lipid absorption, obesity, and fat
levels in blood serum. Aqueous leaf extract considerably
reduced blood glucose levels, serum cholesterol, triglyceride,
hepatic triglyceride, serum leptin, and insulin levels in
Wistar mice [57].
Diabetes is a threat to man leading to stern socio-eco-
nomic and high rate of mortality [95]. Herbal decoction of S.
alata is commonly used in Caribbean [96], Africa [34], and
India [97] for the treatment of diabetes. *e marked
α-glucosidase inhibitory effect and antidiabetic activities
displayed by S. alata are linked to bioactive compounds such
as astragalin and kaempferol-3-O-gentiobioside [31, 98].
Traditionally, the leaves decoction is used in regulation of
sugar level in serum [99] and enhances the defence of hepato
and renal organs to oxidative stress [56]. It also reduces
fasting blood glucose and improves metabolic state via ac-
tivation of PKB/Akt which helps regulate glucose uptake in
the liver and muscles [100].
*e antidiabetic potency of acarbose, n-butanol, and
ethyl acetate fractions of methanolic S. alata leaf extract
was assessed via inhibitory carbohydrate digestion mech-
anism. *e antidiabetic drug (acarbose) significantly in-
hibits α-glucosidase with inhibitory concentration (IC50,
107.31 ± 12.31 µg/ml). n-Butanol and ethyl acetate fractions
displayed inhibitory activities of IC50, 25.80± 2.01 µg/ml
and IC50, 2.95± 0.47 µg/ml, respectively, due to kaempferol
3-O-gentiobioside analysed by HPLC and Combiflash
chromatography [31, 83]. α-Amylase and α-glucosidase
inhibitory potential of acetone, hexane, and ethyl acetate
leaf extracts of S. alata was assessed via Lineweaver–Burk
plot. Acetone extract significantly inhibited α-amylase
(IC50� 6.41mg/mL), while hexane displayed strong inhibi-
tion against α-glucosidase (IC50� 0.85mg/mL). n-Hexane
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substantially reduces (p< 0.05) postprandial blood glucose in
sucrose-induced rats after 2 h of treatment [101].
*e reduction in the oxidative stress in the aorta and
heart of streptozotoc, hyperglycemic rats was investigated by
DPPH free radical scavenging and antioxidant catalase as-
says. *e aqueous leaf extract significantly reduced lipid
peroxidation (MDA levels), blood glucose; however, it in-
creases in the antioxidant catalase and DPPH free radical
scavenging activity was observed. *e reversal of oxidative
stress induced by cardiac dysfunction in hyperglycemic
condition justified the ethnobiological claim of the plant
[102]. In a similar study, the S. alata leaf extract significantly
reduces oxidative stress causing diabetes in treated mice.
Prominent activities were observed in the kidney and liver.
*e activity resulted in critical changes in the urea, protein,
creatinine, and uric acid level in the blood serum [56].
3.4.6. Antimalarial Activities. Malaria is a global threat
contributing to serious sociocultural and health issues in
humid and tropical regions [103, 104]. Chemotherapy re-
ported the antimalarial activities of S. alata could be linked
to quinones, alkaloids, and terpenes [105, 106]. Quinones
isolated from S. alata significantly displayed in vitro anti-
plasmodial activity, against Plasmodium falciparum via the
microdilution test of Desjardin [107]. Terpenes isolated from
S. alata leaves displayed pronounce in vitro antiplasmodial
assays against P. falciparum in ethylene glycol-water frac-
tions. Significant activity was observed at concentration
below 1 µg/ml [108]. *e appraisal of aqueous leaf extract
justifies the ethnomedical applications of S. alata as remedy
for malaria and fever. *e leaf extract considerably inhibited
3D7 strain of the P. falciparum parasite inWistar mice [109].
3.4.7. Anthelmintic Activity. Traditionally, S. alata leaf and
flower decoctions are used in treatment of intestinal worm
infestation and stomach disorder. *e anthelmintic potency
of alcoholic leaves extract of S. alata and T. angustifolia at 10
to 100mg/ml were assessed in clinical isolates of Ascardia
galli and Pheretima posthuma by observing time of paralysis
and point of death of the worms. *e leaves extract sig-
nificantly inhibit the worms (test organisms) more than
piperazine citrate (standard anthelmintic drug) [110].
3.4.8. Antiviral Activities. S. alata is an indispensable bac-
tericidal and fungicidal natural therapy. However, the jus-
tification of antiviral activities is not properly documented.
*e antiviral efficacy of n-hexane, ethyl acetate, butanol, and
aqueous leaf extracts was assessed on dengue virus (DENV)
obtained from an infected pregnant woman in Indonesia via
focus assay. *e extracts significantly inhibited DENV-2
with IC50 (<10 μg/ml), CC50 (645.8 μg/ml) and SI (64.5 μg/
ml) [111].
4. Nutritional Constituents of S. alata
In appraisal of the therapeutic potentials of medicinal
herbs, phytochemical, pharmacological, toxicological, and
nutritional details are indispensable. In appraisal of the
nutritional constituents of S. alata leaf, several nutrients
assessed include moisture content (9.53 ± 0.06), carbohy-
drate (298.61 ± 0.40), crude lipid (47.73 ± 0.01), crude fibre
(18.23 ± 0.13), and ash (15.73 ± 0.03). *e nutritional
contents analysed in flower revealed ash (7.00 ± 1.0), crude
protein (13.14 ± 0.02), carbohydrate (57.04± 0.04), mois-
ture (6.16 ± 0.14), and crude lipid (1.81± 0.09). It is ob-
served that storage capacity, easy absorption of food,
antimicrobial and anaesthetic properties are connected to
the nutritional composition of herbs [112]. Several min-
erals such as potassium, iron, manganese, calcium, zinc,
copper, and chromium have been assessed in S. alata.*ese
mineral constituents help in formulation of herbal drugs
and dietary supplements [113–115].
5. Toxicological Studies of S. alata
Lately, medicinal plants and herbal products have come
under spotlight owing to health hazards connected to in-
discriminate handling of herbs and herbal products. Several
reports were published relating to the use of herbal drugs.
Despite the risks ascribed to most medicinal and herbal
products, the number of herbal users still increases. *is
initiates the appraisal of herbs in an attempt to establish their
safety [116]. *e S. alata leaf extract was appraised by oral
administration ofWistar rats (10 g/kg weight).*e acute and
subacute effects were assessed in every 24 h for 14 days at
different dosages (250, 500, and 1000mg/kg). After 24 h, no
significant variation was observed in the liver, urea, bicar-
bonate, creatinine, and kidney of the tested organisms and
control [117]. Aqueous flower extract at doses of 100, 400,
and 800mg/kg was orally administered to tenWistar rats for
28 days. No significant difference on histological sections of
the lung, liver, kidney, heart, and kidney was observed
during the postmortem analysis of the mice [118].
Different doses (1,000, 2,000, and 3,000mg/kg body
weight) of ethanolic leaf extract do not display any
behavioural, biochemical, haematological, and histopatho-
logical variations in the tested Swiss albino mice and control
after 15 days of oral administration [119]. Hydroethanolic
leaf extract increased the body weight, blood level, liver
homogenates, and serum index after proper monitoring of
the administered rats every 48 h for 26 days. Haematological
parameters assessed displayed dose-dependent response,
however, no significant variation was observed in liver
histopathology [120]. Alkaloids isolated from aqueous S.
alata leaf extract significantly reduces alkaline phosphate,
uric acid, globulin, liver and kidney body weight ratio, urea,
phosphate ions, bilirubin, potassium ions, serum concen-
trations of albumin, creatinine, gamma glutamyl transferase,
alanine transaminases, and aspartate in the liver and kidney
of pregnant rats after periodic observation for 18 days. *is
led to variation in serum enzymes, excretory, and secretory
functions of liver and kidney of the test organisms [61].
Documented toxicological appraisals of S. alata present
positive information regarding its safety; however, there is
need to authenticate these reports through in vitro and in
vivo assessments on clinical isolate. Fresh and dried plant
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parts, low-dosage concentrations, test organisms of different
age groups and effect on other vital organs such as brain,
intestine, and bladder should be considered during toxi-
cological appraisals of medicinal plant or products. Eth-
nobiological appraisals described that ulcer patients,
pregnant women, and children under the age of two should
avoid S. alata decoction. Also, studies should be focused on
appraisals of recommended dosage, safest mode of ad-
ministration, and reaction mechanisms of the metabolites in
living organisms.
6. Limitation,Conclusion, andFutureProspects
Based on this review, further studies on S. alata have become
evident. Most studies focused on lipid-soluble and volatile
components; however, appraisals onmetabolites prepared in
hydrophilic medium are deficient. Most phytochemical
studies of S. alata focused on leaves, stems, and flowers,
though study on seeds and roots are lacking. Many thera-
peutic appraisals have been investigated in cell and animal
experiments; still, there remain important tasks. *ese in-
clude secondary metabolites dictating the pharmacological
activities are not well stated; relatively, few studies analyt-
ically appraised the mechanisms of action of secondary
metabolites; systemic toxicological studies remain ambig-
uous. *e phytochemical appraisals revealed there is a
variation in some metabolites investigated due to geo-
graphical and climatic factors. *is gives room for quali-
tative approach to authenticate the metabolites in this plant.
*e plant secondary metabolites contributed to the pro-
nounced wound healing and antibacterial and antifungal
activities [92, 121]. Industrially, the plant is a key ingredient
in detergents (foaming and surface active agents), mollus-
cicides and pesticides. Summarily, comprehensive ethno-
biological and pharmacological activities of S. alata,
limitations, and future prospects were explored which could
present novel research directions.
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